Ministry of Science & Technology India has developed its first indigenously discovered antibiotic "Nafithromycin", which is effective against resistant respiratory infections, particularly useful for cancer patients and poorly controlled diabetics The antibiotic has been developed by the Govt of India's Department of Biotechnology in collaboration with well-known private pharma house Wockhardt Citing this as an example of successful industry-academia partnership, the Minister emphasizes the need to build a self-sustainable innovation ecosystem, so that India could reduce its dependence on government funding and create a culture of private sector participation and philanthropic support to achieve global recognition in research and innovation Another successful story of government - non government collaboration is a major breakthrough in gene therapy, marking the first successful indigenous clinical trial for Hemophilia treatment Union Minister Dr. Jitendra Singh Inaugurates 3-day Medical Workshop on “Harnessing Artificial Intelligence for Multi-Omics Data Integration and Analysis” India Must Build a Self-Sustainable Innovation Ecosystem to achieve global recognition in research and innovation: Dr. Jitendra Singh Artificial Intelligence to Revolutionize Healthcare and Governance Efficiency, and Decision-Making, said Dr. Jitendra Singh Posted On: 18 OCT 2025 3:01PM by PIB Delhi Union Minister of State (Independent Charge) for Science & Technology; Minister of State for Prime Minister’s Office, Personnel, Public Grievances, Pensions, Department of Atomic Energy and Department of Space, Dr. Jitendra Singh today informed that India has developed its first indigenously discovered antibiotic "Nafithromycin", which is effective against resistant respiratory infections, particularly useful for cancer patients and poorly controlled diabetics. He said this antibiotic is the first molecule entirely conceptualized, developed and clinically validated in India, representing a significant leap toward self-reliance in the pharmaceutical sector. The antibiotic Naphithromycin has been developed by the Govt of India's Department of Biotechnology in collaboration with well-known private pharma house Wockhardt. Citing this as an example of successful industry-academia partnership driving India’s biopharmaceutical growth, the Union Minister emphasized the need to build a self-sustainable innovation ecosystem, so that India could reduce its dependence on government funding and create a culture of private sector participation and philanthropic support to achieve global recognition in research and innovation. Inaugurating the 3-day Medical Workshop on “Harnessing Artificial Intelligence for Multi-Omics Data Integration and Analysis”, Dr. Jitendra Singh said that India must develop a self-sustainable ecosystem to drive its scientific and research growth. He stated that most nations that have achieved global recognition in science and innovation have done so through self-sustaining, innovation-driven models with extensive engagement of the private sector. Citing another successful story of government - non government collaboration, the Minister also announced that India has achieved a major breakthrough in gene therapy, marking the first successful indigenous clinical trial for Hemophilia treatment, the trial for which was supported by Govt of India's Department of Biotechnology and done in a non-government sector hospital, Christian Medical College Vellore. Dr Jitendra Singh further mentioned that India has already sequenced over 10,000 human genomes and aims to scale this up to one million. The gene therapy trial, he added, recorded a 60–70% correction rate with zero bleeding episodes, representing a milestone in India’s medical research landscape. The findings have been published in the New England Journal of Medicine, underscoring India’s growing leadership in advanced biomedical innovation. Speaking at the occasion, Dr. Jitendra Singh said the Anusandhan National Research Foundation (ANRF) is a major step in this direction, with a total outlay of ₹50,000 crore over five years, of which ₹36,000 crore will come from non-government sources. This model, he added, reflects a paradigm shift in India’s approach to research and development, aligning it with global standards and emphasizing greater participation of academia and industry. Dr. Jitendra Singh highlighted that Artificial Intelligence (AI) has become one of the most transformative tools of the modern era, reshaping healthcare accessibility, governance efficiency, and decision-making. He mentioned that AI-based hybrid mobile clinics are already serving rural and remote regions, ensuring quality healthcare for all. He also referred to the AI-driven grievance redressal system developed by the Department of Administrative Reforms and Public Grievances (DARPG), which has achieved a weekly disposal rate of 97–98%, significantly improving citizen satisfaction and service delivery. The Minister lauded institutions like Sir Ganga Ram Hospital for pioneering interdisciplinary approaches by integrating AI, biotechnology and genomics to improve healthcare outcomes. He urged greater collaboration between government departments, private hospitals, and research institutes to realize the vision of Viksit Bharat @2047. Dr. Jitendra Singh said that India is entering a new era of self-reliance in biotechnology, AI and genomic medicine. The convergence of innovation, collaboration and compassion, he said, will define India’s journey toward a developed nation and establish its leadership in the global science and technology landscape. The event was also attended by Dr.Shiv Kumar Kalyanaraman, CEO Anusandhan National Research Foundation, Dr. N.K Ganguly, DR. D.S Rana, and Dr. Ajay Swaroop. **** NKR/AK/SK (Release ID: 2180705)